2269:HKG
WuXi Biologics (Cayman) Inc
HK$४८.२०
arrow_downward
-०.९०%(-०.४४) १ दि
१६ ऑक्टो, ४:०८:१४ PM [GMT]+८ · HKD
search
सर्व सिम्बॉल
| सिम्बॉल | किंमत | बदल | % बदल |
|---|
insights_auto2269 साठी टॉप इनसाइट जनरेट करत आहे...
उघडा
HK$४९.९८
उच्च
HK$५०.८५
कमी
HK$४५.८२
मार्केट कॅप
१.९८ खर्व
सरासरी उलाढाल
३.०४ कोटी
उलाढाल
५.५२ कोटी
P/E रेशो
३४.४८
५२ आठवड्यांतील उच्चांक
HK$५८.००
५२ आठवड्यांतील नीचांक
HK$२८.४८
EPS
HK$१.४०
थकित शेअर
१.२३ अब्ज
कर्मचाऱ्यांची संख्या
१५ ह
उघडा
HK$४९.९८
उच्च
HK$५०.८५
कमी
HK$४५.८२
मार्केट कॅप
१.९८ खर्व
सरासरी उलाढाल
३.०४ कोटी
उलाढाल
५.५२ कोटी
P/E रेशो
३४.४८
५२ आठवड्यांतील उच्चांक
HK$५८.००
५२ आठवड्यांतील नीचांक
HK$२८.४८
EPS
HK$१.४०
थकित शेअर
१.२३ अब्ज
कर्मचाऱ्यांची संख्या
१५ ह
बातम्यांच्या स्टोरी
वेब स्रोत आणि बातमी भागीदारांकडून
ad-hoc-news.de
·
३ तासांपूर्वी
WuXi Biologics stock last traded at EUR 5.42 on October 16, 2026 with a P/ E of 34.45
प्रोफाइल
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
WuXi Biologics (Cayman) Inc बद्दल